Media headlines about athenahealth (NASDAQ:ATHN) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. athenahealth earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave news stories about the health services provider an impact score of 44.8329834535203 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the news stories that may have impacted Accern Sentiment Analysis’s rankings:
- Global Electronic Health Records Markets and Technologies 2018-2022: Key Vendors are Agfa-Gevaert N.V., Amazon.com, Analogic, athenahealth and Beckman Coulter (markets.financialcontent.com)
- Healthicity Partners with athenahealth’s ‘More Disruption Please’ Program to Simplify Healthcare Compliance and Auditing (prweb.com)
- DocSpera Partners with athenahealth’s ‘More Disruption Please’ Program to Streamline Pre- and Post-Operative Coordination and Improve Decision Support (prnewswire.com)
- What’s Driving Orthofix International to a New 52-Week High – Nasdaq (nasdaq.com)
athenahealth (NASDAQ ATHN) traded down $1.60 during trading on Tuesday, hitting $143.01. 268,112 shares of the stock were exchanged, compared to its average volume of 492,658. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.84 and a current ratio of 1.84. athenahealth has a one year low of $95.01 and a one year high of $158.66. The company has a market cap of $5,733.98, a P/E ratio of 109.17, a P/E/G ratio of 2.47 and a beta of 1.17.
Several brokerages have weighed in on ATHN. Bank of America began coverage on shares of athenahealth in a report on Tuesday, February 27th. They set a “neutral” rating and a $147.00 price objective for the company. BidaskClub raised shares of athenahealth from a “strong sell” rating to a “sell” rating in a report on Saturday, February 17th. Piper Jaffray Companies reissued a “buy” rating and set a $160.00 price objective on shares of athenahealth in a report on Friday, February 16th. Royal Bank of Canada set a $141.00 price objective on shares of athenahealth and gave the stock a “hold” rating in a report on Thursday, February 15th. Finally, SunTrust Banks raised their price objective on shares of athenahealth to $180.00 and gave the stock a “buy” rating in a report on Monday, February 5th. Three analysts have rated the stock with a sell rating, seventeen have given a hold rating and seven have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $144.35.
In related news, SVP Bradford Kyle Armbrester sold 2,235 shares of athenahealth stock in a transaction dated Friday, March 2nd. The shares were sold at an average price of $138.70, for a total value of $309,994.50. Following the sale, the senior vice president now directly owns 10,146 shares in the company, valued at approximately $1,407,250.20. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CMO Timothy John O’brien sold 3,064 shares of athenahealth stock in a transaction dated Friday, March 2nd. The shares were sold at an average price of $137.27, for a total transaction of $420,595.28. Following the completion of the sale, the chief marketing officer now owns 11,320 shares in the company, valued at $1,553,896.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 108,705 shares of company stock worth $14,891,199. Insiders own 3.20% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Impact athenahealth (ATHN) Stock Price” was published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://www.tickerreport.com/banking-finance/3282813/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-athenahealth-athn-stock-price.html.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.